Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
Robert W. Gao, Courtney N. Day, Nathan Y. Yu, Aaron Bush, A. Amundson, Pranitha Prodduturvar, Umair Majeed, Emily Butts, Thomas Oliver, Anna J. Schwecke, Jenesse Nicole Moffett, David M. Routman, William G. Breen, Ashley Potter, Joel Rivera‐Concepción, Bradford S. Hoppe, Steven E. Schild, Terence T. Sio, Yanyan Lou, Vinicius Ernani, Stephen Ko, Kenneth R. Olivier, Kenneth W. Merrell, Yolanda I. Garces, Rami Manochakian, William S. Harmsen, Konstantinos Leventakos, Dawn Owen
Topics & Concepts
MedicineDurvalumabPneumonitisLung cancerInternal medicineIncidence (geometry)Radiation therapyLungRadiologyCancerNivolumabImmunotherapyPhysicsOpticsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations